Atomos Limited has turned a corner in FY26, posting over 20% sales growth to around $40 million and swinging to EBITDA profitability after prior losses, boosted by new product launches and the strategic acquisition of Flanders Scientific.
- FY26 sales rise 20% to ~$40 million
- EBITDA swings to $2.5m–$3.5m profit
- Flanders Scientific acquisition expands product range
- Q4 cash flow hit by one-off costs and sales timing
- Debt refinancing cuts interest costs by $0.7 million annually
FY26 Marks a Turning Point for Atomos
After years of losses, Atomos Limited (ASX:AMS) has delivered a transformational FY26, with sales climbing over 20% to approximately $40 million and a return to EBITDA profitability in the range of $2.5 million to $3.5 million. This turnaround contrasts sharply with the $7.4 million EBITDA loss reported in FY25, signalling a successful reset for the Melbourne-based video production technology company.
CEO Peter Barber highlighted a refreshed product suite and strategic expansion as key drivers, noting that the company introduced seven new and upgraded products over the past year, including the Shogun AV-19 and the Sumo PRO 19. The latter earned multiple Best of Show awards at the NAB Trade Show, validating positive customer feedback despite a slightly delayed launch that limited reorders within FY26.
Strategic Acquisition Broadens Market Reach
April 2026 saw Atomos complete the acquisition of Flanders Scientific, a specialist in professional reference monitoring. This move extends Atomos' ecosystem from on-camera solutions through to post-production workflows, aiming to capture a larger share of customer spend. The integration has reportedly exceeded cultural expectations, with Flanders' expertise already being leveraged across Atomos' operations.
The acquisition was funded partly through a new $10 million, three-year business finance facility secured with Commonwealth Bank of Australia. Concurrently, Atomos repriced its existing Monreii Pty Ltd loan facility, reducing the interest rate from 20% to 13% per annum and delivering annual interest savings of approximately $0.7 million.
Cash Flow Challenges in Q4 Reflect One-Off Items
Despite the strong sales growth and profitability, Q4 FY26 presented cash flow headwinds. The company recorded a net operating cash outflow of $5.7 million, impacted by lower-than-expected cash receipts of $6.1 million due to timing of larger sales late in the quarter, and outsized product manufacturing and operating costs of $7.8 million. These costs included a $1 million one-off inventory investment to bolster Flanders' stock and $0.6 million in legacy payment plans.
Additional cash outflows included $0.8 million in one-off settlement payments for legacy property leases in Victoria and stable staff cash costs of approximately $1.9 million for the quarter. At quarter end, Atomos held $2.3 million in cash and cash equivalents, supported by $0.3 million of unused financing facilities.
Outlook Hinges on Working Capital and Sales Momentum
Looking ahead to FY27, Atomos expects operating cash flow to more closely align with EBITDA as the company unwinds its working capital build and one-off costs subside. The management team is confident in the cash position and anticipates that ongoing sales strategies and the expanded product ecosystem will drive profitable sales growth in the short to medium term.
However, the company remains mindful of external uncertainties, including the ongoing Middle East conflict and inflationary pressures in the US, which could influence market dynamics. The success of new products like the Shogun AV-19 and Sumo PRO 19, alongside the integration of Flanders Scientific, will be critical to sustaining momentum.
Bottom Line?
Atomos has turned a corner operationally and financially, but the path to sustained cash flow stability depends on execution of sales strategies and working capital management amid external uncertainties.
Questions in the middle?
- How will Atomos manage the transition from one-off cash outflows to positive operating cash flow in FY27?
- What impact will the Flanders Scientific acquisition have on Atomos’ revenue and profitability beyond initial integration?
- Can the new product launches maintain their positive market reception and translate into consistent sales growth?